DR. ROBERT THOMAS MALISON, M.D.
Psychiatric at Park St, New Haven, CT

License number
Connecticut 030105
Category
Psychiatric
Type
Psychiatry
License number
Connecticut 030105
Category
Psychiatric
Type
Addiction Psychiatry
Address
Address 2
34 Park St, New Haven, CT 06519
3 Salt Meadow View Ln, Guilford, CT 06437
Phone
(203) 974-7557
(203) 974-7662 (Fax)
(203) 453-4946

Personal information

See more information about ROBERT THOMAS MALISON at radaris.com
Name
Address
Phone
Robert Malison, age 64
3 Salt Meadow View Ln, Guilford, CT 06437
Robert T Malison, age 63
3 Salt Meadow View Ln, Guilford, CT 06437

Professional information

See more information about ROBERT THOMAS MALISON at trustoria.com
Robert Thomas Malison Photo 1
Robert Thomas Malison, New Haven CT

Robert Thomas Malison, New Haven CT

Specialties:
Psychiatrist
Address:
34 Park St, New Haven, CT 06519
Education:
Doctor of Medicine
Board certifications:
American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology)


Robert T Malison Photo 2
Dr. Robert T Malison, New Haven CT - MD (Doctor of Medicine)

Dr. Robert T Malison, New Haven CT - MD (Doctor of Medicine)

Specialties:
Addiction Psychiatry
Address:
Clinical Neuroscience Research
34 Park St SUITE 339, New Haven 06519
(203) 974-7557 (Phone)
Certifications:
Addiction Psychiatry, 1998, Psychiatry, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Clinical Neuroscience Research
34 Park St SUITE 339, New Haven 06519
Yale - New Haven Hospital
20 York St, New Haven 06510
Education:
Medical School
Yale University
Graduated: 1987
Hospital Of St Raphael


Robert Thomas Malison Photo 3
Robert Thomas Malison, New Haven CT

Robert Thomas Malison, New Haven CT

Specialties:
Psychiatry, Addiction Psychiatry
Work:
Connecticut Mental Health Center
34 Park St, New Haven, CT 06519
Education:
Yale University (1987)


Robert Malison Photo 4
Methods And Compositions For Treatment Of Drug Addiction

Methods And Compositions For Treatment Of Drug Addiction

US Patent:
2010010, Apr 29, 2010
Filed:
Mar 6, 2008
Appl. No.:
12/530471
Inventors:
David Weinshenker - Atlanta GA, US
Robert T. Malison - Guilford CT, US
International Classification:
A61K 31/415, A61P 25/30, C12Q 1/68
US Classification:
514392, 435 6
Abstract:
The present disclosure relates to methods of treating a stimulant addiction of a patient comprising administering to a patient in need a therapeutically effective dose of a selective dopamine β-hydroxylase inhibitor thereby decreasing stimulant reward, inducing aversion for the stimulant or preventing relapse in the patient. The disclosure further encompasses methods whereby a therapeutically effective dose of a selective dopamine β-hydroxylase inhibitor is determined by: characterizing the genetic profile of the patient with respect to the gene encoding dopamine β-hydroxylase, a polymorphism therein correlating to the level of endogenous dopamine β-hydroxylase activity in the patient before administering the therapeutic agent.